On 2025-05-13, Allogene Therapeutics, Inc. (ALLO) announced earnings per share of $-0.28 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.28.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.28 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.28 | $-0.28 |
| 2025-03-13 | 2024-12-31 | $-0.34 | $-0.28 |
| 2024-11-07 | 2024-09-30 | $-0.34 | $-0.27 |
| 2024-08-07 | 2024-06-30 | $-0.35 | $-0.32 |
| 2024-05-13 | 2024-03-31 | $-0.38 | $-0.38 |
| 2024-03-14 | 2023-12-31 | $-0.47 | $-0.43 |
| 2023-11-02 | 2023-09-30 | $-0.53 | $-0.37 |
| 2023-08-02 | 2023-06-30 | $-0.59 | $-0.53 |
| 2023-05-03 | 2023-03-31 | $-0.63 | $-0.68 |
| 2023-02-28 | 2022-12-31 | $-0.71 | $-0.66 |
| 2022-11-02 | 2022-09-30 | $-0.62 | $-0.58 |
| 2022-08-09 | 2022-06-30 | $-0.61 | $-0.52 |
| 2022-05-04 | 2022-03-31 | $-0.59 | $-0.56 |
| 2022-02-23 | 2021-12-31 | $-0.61 | $-0.54 |
| 2021-11-04 | 2021-09-30 | $-0.56 | $-0.57 |
| 2021-08-04 | 2021-06-30 | $-0.55 | $-0.53 |
| 2021-05-05 | 2021-03-31 | $-0.48 | $-0.25 |
| 2021-02-25 | 2020-12-31 | $-0.56 | $-0.53 |
| 2020-11-04 | 2020-09-30 | $-0.55 | $-0.52 |
| 2020-08-05 | 2020-06-30 | $-0.55 | $-0.53 |
| 2020-05-06 | 2020-03-31 | $-0.57 | $-0.50 |
| 2020-02-27 | 2019-12-31 | $-0.69 | $-0.58 |
| 2019-11-05 | 2019-09-30 | $-0.54 | $-0.50 |
| 2019-08-07 | 2019-06-30 | $-0.47 | $-0.41 |
| 2019-05-07 | 2019-03-31 | $-0.41 | $-0.32 |
| 2019-03-08 | 2018-12-31 | $-0.23 | $-0.35 |